Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


MaxDiscovery™ In Cell ELISA Kit

Product Description
The MaxDiscovery™ In Cell ELISA Kit is an enzyme immunoassay for quantitative protein analysis directly in adherent cell cultures—there is no need to lyse cells or run protein gels. The technique can be thought of as an ELISA performed on fixed, permeablized cells rather than on immobilized antigen. Like most ELISA assays, protein is detected using a series of two antibodies, a primary antibody for the protein of interest (not provided with the kit) and an enzyme-conjugated secondary antibody. The protein:antibody complex is visualized by adding an enzyme substrate that, when catalyzed, changes the color of the assay solution within the well of the tissue culture plate so that it can be read in a spectrophotometer at 450 nm. The relative amount of protein in the cells will be directly proportional to the amount of signal that is obtained, making this a simple, convenient, and accurate technique for quantifying specific protein levels within cell lines. The MaxDiscovery™ In Cell ELISA Kit contains materials for washing, fixing, and permeablizing cells in culture. HRP-conjugated anti-mouse and anti-rabbit secondary antibodies are included in the kit so that user-supplied primary antibodies from either mouse or rabbit may be used for detection of the protein of interest. In addition, the kit includes mouse-derived antibody targeting glyceraldehyde 3-phosphate dehydrogenase (GAPDH). GAPDH is one of the key enzymes involved in glycolysis, and because of its high-level, and constitutive expression, it is widely used as a loading control for Northern/Western blots and for protein normalization. The quantity of GAPDH in a sample is directly proportional to the number of cells in the sample. GAPDH expression is often used as an internal control in gene expression studies. Typically, GAPDH expression is used to normalize expression signal from the gene-of-interest with respect to cell number. This has been particularly useful for RNAi studies or other drug treatment studies. The MaxDiscovery™ In Cell ELISA assay makes it easy to quickly measure levels of GAPDH (positive control) or your protein-of-interest directly in cultured cells for relative quantitative analysis.
Product MaxDiscovery™ In Cell ELISA Kit
Company BIOO Scientific - Product Directory
Price Request a quote
More Information View company product page
Catalog Number 3440-02
Quantity 2 x 96 wells
Company Logo

BIOO Scientific - Product Directory
3913 Todd Lane Suite 312 Austin, TX 78744, USA

Tel: +1 512-707-8993
Fax: +1 512-707-8122
Email: info@biooscientific.com



Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Biomarker for Parkinson's Disease Found in Urine Samples
Protein identified as Parkinson's biomarker sourced from patient's stored frozen urine samples.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!